| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972151 | The Journal of Heart and Lung Transplantation | 2009 | 7 Pages |
Abstract
The rate of thromboembolism during long-term outpatient support with the HeartMate II is low. The low number of thrombotic events appears to be offset by a greater number of hemorrhagic events. An appropriate target INR is 1.5 to 2.5 in addition to aspirin therapy. In patients having recurrent episodes of bleeding, the risk of lowering the target INR appears to be small.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew J. MD, Stuart D. MD, Jeffrey J. MD, Mark S. MD, Nader MD, Francis D. MD, O. Howard MD, Gerald MS, David J. PhD, Ranjit MD,